Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
IBRN vs BBC
Shared holdings
15
IBRN covered by BBC
11.96%
BBC covered by IBRN
11.96%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
IBRN (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| BlackRock Cash Funds: Institutional, SL Agency Shares | 11.74% | |
| PRAXIS PRECISION MEDICINES INC | 4.43% | |
| AXSOME THERAPEUTICS INC | 4.32% | |
| ALKERMES PLC | 4.02% | |
| BIOGEN INC | 3.47% | |
| SCHOLAR ROCK HOLDING CORP | 3.45% | |
| PTC THERAPEUTICS INC | 3.42% | |
| DENALI THERAPEUTICS INC | 3.27% | |
| ARGENX SE SPONSORED ADR | 3.26% | |
| ACADIA PHARMACEUTICALS INC | 3.20% | |
| XENON PHARMACEUTICALS INC | 3.19% | |
| CATALYST PHARMACEUTICALS INC | 3.12% | |
| NEUROCRINE BIOSCIENCES INC | 3.06% | |
| SUPERNUS PHARMACEUTICALS INC | 3.04% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 2.73% | |
| SK BIOPHARMS. CO LTD | 2.65% | |
| EDGEWISE THERAPEUTICS INC | 2.49% | |
| AVADEL PHARMACEU | 2.33% | |
| SAREPTA THERAPEUTICS INC | 2.33% | |
| DYNE THERAPEUTICS INC | 2.17% | |
| DIANTHUS THERAPEUTICS INC | 2.17% | |
| H LUNDBECK A/S | 2.08% | |
| AXOGEN INC | 1.81% | |
| BIOARCTIC AB | 1.61% | |
| BIOHAVEN LTD | 1.48% | |
| NEUREN PHARMACEU | 1.45% | |
| TAYSHA GENE THERAPIES INC | 1.17% | |
| TOBII DYNAVOX AB | 1.10% | |
| CAPRICOR THERAPEUTICS INC | 1.02% | |
| IDORSIA LTD | 0.91% | |
| ANNEXON INC | 0.89% | |
| RAPPORT THERAPEUTICS INC | 0.87% | |
| INTEGRA LIFESCIENCES HLDS CORP | 0.85% | |
| SANBIO CO LTD | 0.80% | |
| ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD | 0.71% | |
| Bright Minds Biosciences Inc COM NEW | 0.70% | |
| MEDINCELL SA | 0.64% | |
| FULCRUM THERAPEUTICS INC | 0.60% | |
| REGENXBIO INC | 0.60% | |
| MICROPORT NEUROTECH LTD | 0.54% | |
| CERIBELL INC | 0.53% | |
| ANAVEX LIFE SCIENCES CORP | 0.49% | |
| VANDA PHARMACEUTICALS INC | 0.48% | |
| BENITEC BIOPHARMA INC | 0.46% | |
| NEUROPACE INC | 0.45% | |
| PEIJIA MEDICAL LTD | 0.44% | |
| PROTHENA CORP PLC COMMON STOCK USD.01 | 0.44% | |
| SOLID BIOSCIENCES INC | 0.43% | |
| ONCOLYS BIOPHARMA INC | 0.37% | |
| CLEARPOINT NEURO INC | 0.36% |
BBC (April 30, 2026)
| Security | Weight | |
|---|---|---|
| DREYFUS GOVT CASH MGMT FUND | 2.23% | |
| ERASCA INC | 2.14% | |
| ENLIVEN THERAPEUTICS INC | 1.77% | |
| TANGO THERAPEUTICS INC | 1.67% | |
| ORUKA THERAPEUTICS INC | 1.64% | |
| SPYRE THERAPEUTICS INC | 1.60% | |
| ALUMIS INC | 1.55% | |
| DIANTHUS THERAPEUTICS INC | 1.51% | |
| KODIAK SCIENCES INC | 1.32% | |
| REVOLUTION MEDICINES INC | 1.32% | |
| CORVUS PHARMACEUTICALS INC | 1.31% | |
| REZOLUTE INC | 1.29% | |
| DEFINIUM THERAPEUTICS INC | 1.26% | |
| CG ONCOLOGY INC | 1.18% | |
| JADE BIOSCIENCES INC | 1.18% | |
| INHIBRX BIOSCIENCES INC | 1.17% | |
| RELAY THERAPEUTICS INC | 1.17% | |
| GH RESEARCH PLC | 1.14% | |
| NEKTAR THERAPEUTICS | 1.12% | |
| TYRA BIOSCIENCES INC | 1.11% | |
| VIR BIOTECHNOLOGY INC | 1.10% | |
| INTELLIA THERAPEUTICS INC | 1.08% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 1.08% | |
| ANAPTYSBIO INC | 1.06% | |
| OMEROS CORP | 1.04% | |
| TECTONIC THERAPEUTIC INC | 1.02% | |
| ALLOGENE THERAPEUTICS INC | 1.02% | |
| COMPASS Pathways PLC, ADR | 0.97% | |
| EDGEWISE THERAPEUTICS INC | 0.95% | |
| PALVELLA THERAPEUTICS INC | 0.94% | |
| CAPRICOR THERAPEUTICS INC | 0.93% | |
| VAXCYTE INC | 0.93% | |
| PHARVARIS NV | 0.93% | |
| ARRIVENT BIOPHARMA INC | 0.92% | |
| XENON PHARMACEUTICALS INC | 0.92% | |
| NEUROGENE INC | 0.90% | |
| SUMMIT THERAPEUTICS INC | 0.88% | |
| AMYLYX PHARMACEUTICALS INC | 0.88% | |
| CELLDEX THERAPEUTICS INC | 0.86% | |
| PRAXIS PRECISION MEDICINES INC | 0.86% | |
| ARCUS BIOSCIENCES INC | 0.86% | |
| ANNEXON INC | 0.85% | |
| TERNS PHARMACEUTICALS INC | 0.85% | |
| LIQUIDIA TECHNOLOGIES INC | 0.85% | |
| MONTE ROSA THERAPEUTICS INC | 0.85% | |
| IMMUNOME INC | 0.85% | |
| BICARA THERAPEUTICS INC | 0.84% | |
| CELCUITY INC | 0.83% | |
| IRONWOOD PHARMA CL A (PEND) | 0.83% | |
| AbCellera Biologics Inc COM | 0.83% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.